Healthlead PCL

Healthlead PCL EBITDA per Share

The EBITDA per Share of Healthlead PCL (HL.BK) as of Oct 23, 2026 is 0.28 THB. In the previous year, EBITDA per Share was 0.39 THB — a change of -30.12% (lower).

EBITDA per Share

0.28THB

YoY

-30.12%

Last updated:

EBITDA per Share of Healthlead PCL is 2025 0.28 THB. EBITDA per Share of Healthlead PCL was 2024 0.39 THB. It decreases by -30.12% lower compared to the previous year.

The Healthlead PCL EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.01 THB
Jan 1, 2019
0.17 THB
Jan 1, 2020
0.29 THB
Jan 1, 2021
0.38 THB
Jan 1, 2022
0.55 THB
Jan 1, 2023
0.38 THB
Jan 1, 2024
0.39 THB
Jan 1, 2025
0.28 THB
The Healthlead PCL EBITDA per Share history
YEAREBITDA per ShareYoY
0.28THB-30.12%
0.39THB+4.28%
0.38THB-30.58%
0.55THB+44.58%
0.38THB+27.95%
0.29THB+77.48%
0.17THB-3,069.08%
-0.01THB-75.23%
-0.02THB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Healthlead PCL Stock analysis

What does Healthlead PCL do? Healthlead PCL operates pharmacies under four brands: Icare, Pharmax, vitaminclub, and Super Drug. The company distributes medicines, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and other health products through these branded outlets. It sells over 10,000 SKUs of healthcare items including medicines, supplements, and medical devices to meet diverse customer demands. The PRIME brand offers dietary supplements as part of its product portfolio. The company's revenue streams come from pharmacy sales across its four brand names and the distribution of healthcare products. Its subsidiaries handle the invention, development, importing, and distribution of medical supplies and health-related goods. Healthlead PCL targets retail consumers seeking healthcare products through its physical pharmacy locations and online services. The firm serves customers needing medicines, dietary supplements, medical equipment, and household healthcare items. Healthlead PCL's business model combines direct retail sales via its branded pharmacies with distribution of health products to various markets. The company focuses on offering a wide range of health-related products under its four pharmacy brands and the PRIME supplement line. Its operations include both the sale of products in-store and the distribution of goods to meet consumer needs for healthcare solutions. Healthlead PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Healthlead PCL stock

EBITDA per Share of Healthlead PCL is 0.28 THB in 2025.

EBITDA per Share of Healthlead PCL changed from 0.39 THB to 0.28 THB, representing a -30.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Healthlead PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Healthlead PCL

All Key Metrics — Healthlead PCL